Literature DB >> 1683999

Pancreatic enzyme supplements in cystic fibrosis.

G Morrison, J Morrison, A Redmond, C Byers, K McCracken, J A Dodge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1683999     DOI： 10.1016/0140-6736(91)92421-w

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Enzyme contents of pancreatic extract preparations. Are they optimal?

Authors:  S Maguire; M C Goodchild
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

2.  Fibrosing colonopathy in children with cystic fibrosis.

Authors:  J M Littlewood
Journal:  Postgrad Med J       Date:  1996-03       Impact factor: 2.401

Review 3.  Subclinical colonic thickening.

Authors:  P J Oades; M Rosenthal; E J Mac Sweeney; A Bush
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

4.  A double blind lipase for lipase comparison of a high lipase and standard pancreatic enzyme preparation in cystic fibrosis.

Authors:  I M Bowler; S P Wolfe; H M Owens; T A Sheldon; J M Littlewood; M P Walters
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

5.  Pancreatic enzyme replacement therapy for people with cystic fibrosis.

Authors:  Usha Rani R Somaraju; Arturo Solis-Moya
Journal:  Cochrane Database Syst Rev       Date:  2020-08-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.